2025-04-02

While we wait for a Bloodborne remake or sequel, FromSoftware just announced The Duskbloods, a brand new Switch 2 exclusive

FromSoftware has unveiled its next major title The Duskbloods. [...]

2025-04-02

Microsoft reveals new tool to help with Windows 11 boot recovery crashes

Users can now enable Quick Machine Recovery (QMR) for quicker fixes on post-Windows 11 boot crashes. [...]

2025-04-02

Amazon reportedly wants to buy TikTok now too

Amazon has reportedly joined the growing list of suitors angling to acquire TikTok as a new ban deadline approaches. According to The New York Times, the retailer has made a “last-minute bid” to b [...]

2025-04-02

This Lenovo ThinkPad I tested breaks a decade-long design streak - and it looks fantastic

The ThinkPad X9 Aura Edition is a new take on the iconic workhorse line, with a new design concept and features aimed at MacBook users. [...]

2025-04-02

Nintendo’s best Switch 2 announcement was its GameCube game rereleases, but buying the new GameCube controller will be a challenge

Pokémon Colosseum and other fantastic GameCube rereleases might convince me to pre-order a Nintendo Switch 2. [...]

2025-04-02

What you need to know about Amazon Nova Act: the new AI agent SDK challenging OpenAI, Microsoft, Salesforce

An experimental developer kit for building AI agents that can navigate the web and complete tasks autonomously, powered by Amazon Nova. [...]

2025-04-02

Samsung's New Galaxy Tab S10 FE and FE Plus Tablets Get a Couple of Key Upgrades

Samsung's latest midrange Fan Edition tablets have been upgraded with the company's Exynos 1580 processor, and the Tab S10 FE Plus has a larger display than its predecessor. [...]

2025-04-02

Genres are bustin’ out all over in Strange New Worlds S3 teaser

"We want to give audiences a reflection of their own world through the lens of fantasy." [...]

2025-04-02

Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options

Hims & Hers (HIMS) stock slid Wednesday, a day after the company announced new weight-loss drug offerings — an update that left investors unimpressed.Read more... [...]